Futura Medical Future Growth
Future criteria checks 0/6
Futura Medical's revenue is forecast to decline at 28.7% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 13.9% |
Revenue growth rate | -28.7% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 19 May 2025 |
Recent future growth updates
Recent updates
Futura Medical plc (LON:FUM) Shares Slammed 48% But Getting In Cheap Might Be Difficult Regardless
Jan 31Need To Know: Analysts Are Much More Bullish On Futura Medical plc (LON:FUM)
Sep 13We Think Futura Medical (LON:FUM) Can Easily Afford To Drive Business Growth
Apr 17Here's Why We're Not At All Concerned With Futura Medical's (LON:FUM) Cash Burn Situation
Jan 05Is Futura Medical (LON:FUM) In A Good Position To Invest In Growth?
Jul 28We Think Futura Medical (LON:FUM) Needs To Drive Business Growth Carefully
Mar 18We're Keeping An Eye On Futura Medical's (LON:FUM) Cash Burn Rate
Sep 25Here's Why We're Not Too Worried About Futura Medical's (LON:FUM) Cash Burn Situation
May 10We're Interested To See How Futura Medical (LON:FUM) Uses Its Cash Hoard To Grow
Jan 10What We Learned About Futura Medical's (LON:FUM) CEO Compensation
Dec 21Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2027 | 7 | N/A | -1 | N/A | 1 |
12/31/2026 | 5 | N/A | -2 | N/A | 1 |
12/31/2025 | 5 | N/A | -3 | N/A | 1 |
12/31/2024 | 14 | 1 | -1 | 0 | N/A |
9/30/2024 | 11 | -1 | -3 | -1 | N/A |
6/30/2024 | 8 | -4 | -4 | -2 | N/A |
3/31/2024 | 6 | -5 | -3 | -1 | N/A |
12/31/2023 | 3 | -7 | -1 | 1 | N/A |
9/30/2023 | 2 | -6 | -2 | -1 | N/A |
6/30/2023 | 2 | -5 | -3 | -3 | N/A |
3/31/2023 | 1 | -5 | -5 | -4 | N/A |
12/31/2022 | N/A | -6 | -7 | -6 | N/A |
9/30/2022 | N/A | -6 | -6 | -6 | N/A |
6/30/2022 | N/A | -6 | -6 | -5 | N/A |
3/31/2022 | N/A | -5 | -5 | -5 | N/A |
12/31/2021 | N/A | -5 | -4 | -4 | N/A |
9/30/2021 | N/A | -4 | -4 | -4 | N/A |
6/30/2021 | N/A | -3 | -3 | -3 | N/A |
3/31/2021 | N/A | -3 | -4 | -4 | N/A |
12/31/2020 | N/A | -2 | -5 | -5 | N/A |
9/30/2020 | 0 | -4 | -5 | -5 | N/A |
6/30/2020 | 0 | -6 | -6 | -6 | N/A |
3/31/2020 | 0 | -7 | -6 | -6 | N/A |
12/31/2019 | 0 | -9 | -7 | -7 | N/A |
9/30/2019 | 0 | -9 | -6 | -6 | N/A |
6/30/2019 | N/A | -8 | -6 | -6 | N/A |
3/31/2019 | N/A | -7 | -5 | -5 | N/A |
12/31/2018 | N/A | -6 | -5 | -5 | N/A |
9/30/2018 | 0 | -5 | N/A | -4 | N/A |
6/30/2018 | 0 | -4 | N/A | -4 | N/A |
3/31/2018 | 0 | -4 | N/A | -4 | N/A |
12/31/2017 | 0 | -4 | N/A | -4 | N/A |
9/30/2017 | 0 | -4 | N/A | -4 | N/A |
6/30/2017 | 0 | -3 | N/A | -4 | N/A |
3/31/2017 | 0 | -4 | N/A | -4 | N/A |
12/31/2016 | 0 | -4 | N/A | -3 | N/A |
9/30/2016 | 0 | -4 | N/A | -4 | N/A |
6/30/2016 | 0 | -5 | N/A | -4 | N/A |
3/31/2016 | 0 | -5 | N/A | -5 | N/A |
12/31/2015 | 0 | -5 | N/A | -5 | N/A |
9/30/2015 | 0 | -5 | N/A | -5 | N/A |
6/30/2015 | 0 | -4 | N/A | -4 | N/A |
3/31/2015 | 0 | -4 | N/A | -4 | N/A |
12/31/2014 | 0 | -3 | N/A | -3 | N/A |
9/30/2014 | 0 | -3 | N/A | -3 | N/A |
6/30/2014 | 0 | -3 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if FUM's forecast earnings growth is above the savings rate (2.5%).
Earnings vs Market: Insufficient data to determine if FUM's earnings are forecast to grow faster than the UK market
High Growth Earnings: Insufficient data to determine if FUM's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: FUM's revenue is expected to decline over the next 3 years (-28.7% per year).
High Growth Revenue: FUM's revenue is forecast to decline over the next 3 years (-28.7% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if FUM's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/05/21 07:58 |
End of Day Share Price | 2025/05/21 00:00 |
Earnings | 2024/12/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Futura Medical plc is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Navid Malik | Cavendish Historical (Cenkos Securities) |
Francesco Gregori | Edison Investment Research |
Sebastien Jantet | Panmure Liberum |